# Chemfab Alkalis share price today (Chemfab Alkalis Ltd, NSE: CHEMFAB)

> Chemfab Alkalis share price today: ₹302.05 at the NSE close on 3 November 2026, down 50.4% in a year. Chemfab Alkalis (NSE: CHEMFAB) is worth ₹435 crore, trades at a P/E of 435.0 and has closed between ₹291.35 and ₹555.90 over the past 52 weeks. > Chemfab Alkalis Ltd's results are improving, and its P/E is near the top of its own history, higher than 96% of past readings. CHEMFAB · Chemicals - Inorganic - Caustic Soda/Soda Ash · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/chemfab-alkalis-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹302.05 (−50.4% in a year)
- P/E: 435.0× (higher than 96% of the last 5.6 years)
- Revenue (Jun 2026): ₹73.2 Cr (−20.1% on a year ago)
- Profit (Jun 2026): ₹5.7 Cr (+124.7% on a year ago)
- Operating margin: 13.8% (+1.5 points on a year ago)
- ROCE: 1%, FY26
- ROIC: −0.7%, against a 12.0% cost of capital: −12.7 points

The main question: results are strong, and the P/E is higher than 96% of its own history. ## What is the Chemfab Alkalis share price today? Chemfab Alkalis Ltd's share price was ₹302.05 at the close on 3 November 2026. It has been falling for 80 weeks. That is 27.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹291 and ₹556, and at that close it sat 4% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 7 weeks running. Over the last 8.5 years the share price moved +34% while the NIFTY 500 moved +132%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 25 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What are Chemfab Alkalis' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Chemfab Alkalis reported revenue of ₹73.2 crore, down 20.1% from ₹91.5 crore a year earlier, and a profit of ₹5.73 crore, up 124.7% from ₹2.55 crore. ### Chemfab Alkalis results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹73.2 crore | ₹91.5 crore | −20.1% |
| Profit | ₹5.73 crore | ₹2.55 crore | +124.7% |
| Earnings per share | ₹3.99 | ₹1.78 | +124.2% |
| Operating margin | 13.8% | 12.3% | +1.5 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Chemfab Alkalis share price history? Chemfab Alkalis closed at ₹302.05 on 3 November 2026, down 50.4% from ₹608.85 a year earlier (31 October 2025) and up 75.6% over five years. Its highest weekly close since April 2018 was ₹1,132.85 on 1 November 2024. ### Chemfab Alkalis share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹294.50 | +2.6% |
| 1 month ago · 1 Oct 2026 | ₹328.35 | −8.0% |
| 6 months ago · 30 Apr 2026 | ₹408.70 | −26.1% |
| 1 year ago · 31 Oct 2025 | ₹608.85 | −50.4% |
| 3 years ago · 3 Nov 2023 | ₹365.40 | −17.3% |
| 5 years ago · 4 Nov 2021 | ₹172.00 | +75.6% |
| Earliest weekly close in our records · 27 Apr 2018 | ₹226.00 | +33.7% |
| Highest weekly close since April 2018 · 1 Nov 2024 | ₹1,132.85 | −73.3% |
| Lowest weekly close since April 2018 · 27 Mar 2020 | ₹97.40 | +210.1% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹555.90 | −45.7% |
| 52-week low (weekly close) · 30 Oct 2026 | ₹291.35 | +3.7% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (450 weekly closes from 27 April 2018 to 3 November 2026.)

## What is the latest news on Chemfab Alkalis? 3 Nov 2026: Chemfab Alkalis closed at ₹302.05, up 2.6% on the week and down 8.0% on the month. 2 Sep 2026: ex-date for a dividend of ₹1.25 a share. ### Earlier

- Results for April to June 2026: Revenue down 20.1% and profit up 124.7% on a year earlier. ## What dividend does Chemfab Alkalis pay? Chemfab Alkalis paid ₹1.25 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.41% at the ₹302.05 close on 3 November 2026. The last was a dividend of ₹1.25 a share, ex-date 2 September 2026. ### Chemfab Alkalis dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 2 Sep 2026 | ₹1.25 | Dividend | same day |
| 4 Sep 2025 | ₹1.25 | Dividend | 5 Sep 2025 |
| 13 Sep 2024 | ₹1.25 | Dividend | same day |
| 22 Aug 2023 | ₹1.25 | Dividend | n/a |
| 7 Sep 2022 | ₹1.25 | Dividend | n/a |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 4 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. Chemfab Alkalis Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 4 of its last 7 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Chemfab Alkalis on? Chemfab Alkalis is not on any of our India lists this week. ## Is Chemfab Alkalis profitable? Chemfab Alkalis Ltd earned ₹5.7 Cr of net profit in the Jun 2026 quarter, +124.7% on the same quarter a year earlier. The full FY26 year was a loss of ₹3.0 Cr. That is 7.8% of the quarter's revenue. The same quarter a year earlier earned ₹2.5 Cr. 4 of the last 12 reported quarters were loss-making. ## How much revenue does Chemfab Alkalis make, and is it growing? Chemfab Alkalis Ltd reported ₹73.2 Cr of revenue in the Jun 2026 quarter, −20.1% on the same quarter a year earlier. Over 6 years it has grown 7.2% a year on average. The last full year, FY26, came in at ₹311 Cr. The last four reported quarters add to ₹293 Cr. FY26 revenue was ₹311 Cr, −6.9% on the year before. Recent pace: the last four quarters grew −16.0% on average, against 7.2% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −16.2%, against −5.1% a year over the last 8 quarters (rolling over). ## How much of every ₹100 of sales does Chemfab Alkalis keep? Chemfab Alkalis Ltd's operating margin was 13.8% in the Jun 2026 quarter, 1.5 percentage points higher than the same quarter a year ago. Across 7 years it has been between 9.0% and 33.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +1.5 percentage points on the year while gross margin changed −1.3 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Chemfab Alkalis' profit turning into cash? Over the last 3 years, 149% of Chemfab Alkalis Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹38.0 Cr of operating cash against −₹3.0 Cr of profit. After ₹93.0 Cr of spending on assets, free cash was −₹55.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 149% of profit came in as cash: the cash cycle got 54 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 3.3× depreciation over three years. The next section checks what that spending is building. ## Where does Chemfab Alkalis' cash go? Chemfab Alkalis Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 9 days in FY26, up from −45 days in FY21. It spent ₹281 Cr on assets over the last 3 years. Customers take 28 days to pay, and stock sits for 92 days on average. At FY26 sales of ₹311 Cr, each day of that cycle ties up about ₹0.9 Cr, so roughly ₹8.0 Cr is tied up in the business at any time. FY26: customers took 28 days to pay and stock sat for 92 days, about 3.0 months of sales sitting as stock, for a full cycle of 9 days, longer than FY21's −45. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 92 days. Customers pay about 28 days after that. Suppliers are paid at 111 days. Together that makes the 9-day cycle. Spending on assets: ₹281 Cr over the last 3 years, against ₹86.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹31.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Chemfab Alkalis' P/E ratio, and how does it compare with its own history? Chemfab Alkalis Ltd's P/E is 435.0×, near the high end of its own history: higher than 96% of past readings. Its usual P/E (the middle reading) is 13.9×, over 5.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Where the price move came from: over 5 years the price moved +11.9% a year; about −40.5% a year came from earnings growth and about +52.4 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Chemfab Alkalis business getting better or worse? Chemfab Alkalis Ltd's business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −16.2% in the latest quarter, against +7.6% at its best in 12 quarters, with ROCE steady at 1.2%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Chemfab Alkalis earn on its capital? Chemfab Alkalis Ltd earned a ROCE of 1% in FY26. Its return on capital used (ROIC) is 12.7 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −1.0% net margin and 0.54× asset turnover (sales divided by assets). Why the return is what it is (FY26): a −1.0% net margin × 0.54× asset turnover × 1.54× leverage (assets divided by equity) ≈ −0.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −0.7% − 12.0% = −12.7 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Chemfab Alkalis have too much debt? Chemfab Alkalis Ltd has total debt of ₹126 Cr against shareholder equity of ₹375 Cr as of Jun 2026, so its debt is 0.34× its equity. Year by year, that ratio went from 0.03 in FY22 to 0.34 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Chemfab Alkalis shareholding pattern? No group of Chemfab Alkalis Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved −0.2 points over the same period, to 0.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: −0.7 points over 8 quarters, to 72.1%; Foreign institutions: −0.2 points over 8 quarters, to 0.0%; Domestic institutions: +0.0 points over 8 quarters, to 0.1%. ## How far is Chemfab Alkalis from balance-sheet trouble? For Chemfab Alkalis Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Chemfab Alkalis rank in its industry? 43.1 out of 100, rank 5 of 7 in Chemicals - Inorganic - Caustic Soda/Soda Ash, with 56% of the evidence available. Chemfab Alkalis Ltd scores 43.1 out of 100 against the 7 companies it is compared with in Chemicals - Inorganic - Caustic Soda/Soda Ash, ranking 5. Some evidence is missing, so the score is pulled toward the middle on purpose. The three scored parts add up to the total exactly: 25.8 + 4.8 + 12.5 = 43.1 (no relative-strength reading this week; its 20 points are shared across the other three). This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Chemfab Alkalis compared with? Chemfab Alkalis ranks 5 of 7 Chemicals - Inorganic - Caustic Soda/Soda Ash companies on the 4-Factor Sector Score, with 43.1 out of 100. 1. [TGV Sraac Ltd](https://www.sectoralpha.in/stocks/tgv-sraac-ltd) TGVSL · breaking out · Most evidence points up · 81% evidence 68.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.9/35 · Revenue 7.6% · Profit 16.9% · Operating margin change -1 points · 88% evidence Capital efficiency 17.7/25 · ROCE 13% · Operating margin 18% · 100% evidence Valuation 16.2/20 · P/E 8.4× · PEG 0.19 · 100% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 9.7% · 1 year -9.2% · 25% evidence · 5 of 5 weeks ahead Exact sum: 21.9 + 17.7 + 16.2 + 12.5 = 68.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Gujarat Alkalies & Chemicals Ltd](https://www.sectoralpha.in/stocks/gujarat-alkalies-chemicals-ltd) GUJALKALI · losing its lead · Evidence leans up · 81% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.1/35 · Revenue 7.1% · Profit 100% · Operating margin change 9 points · 65% evidence Capital efficiency 8.6/25 · ROCE 1.4% · Operating margin 18% · 100% evidence Valuation 13.5/20 · P/E 59.9× · PEG 0.15 · 65% evidence Relative strength 10.3/20 · Lead over its industry 4.1% · Lead over NIFTY 500 -4.3% · 1 year -5.4% · 100% evidence · 5 of 12 weeks ahead Exact sum: 23.1 + 8.6 + 13.5 + 10.3 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [GHCL Ltd](https://www.sectoralpha.in/stocks/ghcl-ltd) GHCL · quiet · Evidence leans down · 100% evidence 49.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.5/35 · Revenue 1.7% · Profit -4.9% · Operating margin change 1 points · 100% evidence Capital efficiency 18.6/25 · ROCE 17.6% · Operating margin 23% · 100% evidence Valuation 13.8/20 · P/E 6.9× · PEG 1.14 · 100% evidence Relative strength 2.9/20 · Lead over its industry -9.7% · Lead over NIFTY 500 -16.9% · 1 year -41.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 14.5 + 18.6 + 13.8 + 2.9 = 49.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 4. [Tuticorin Alkali Chemicals & Fertilizers Ltd](https://www.sectoralpha.in/stocks/tuticorin-alkali-chemicals-fertilizers-ltd) TUTIALKA · quiet · Evidence leans down · 71% evidence 47.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.0/35 · Revenue 9.3% · Profit -6.7% · Operating margin change -11.2 points · 88% evidence Capital efficiency 17.6/25 · ROCE 22.2% · Operating margin 13.3% · 100% evidence Valuation 8.8/20 · P/E 17.3× · PEG n/a · 50% evidence Relative strength 8.8/20 · Lead over its industry n/a · Lead over NIFTY 500 -10.3% · 1 year -32.7% · 25% evidence · 0 of 5 weeks ahead Exact sum: 12 + 17.6 + 8.8 + 8.8 = 47.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. Chemfab Alkalis Ltd this page CHEMFAB · Too little evidence to rank firmly · 56% evidence 43.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.8/43.75 · Revenue -16.2% · Profit 95.3% · Operating margin change 1.5 points · 88% evidence Capital efficiency 4.8/31.25 · ROCE 1% · Operating margin 13.8% · 100% evidence Valuation 12.5/25 · P/E n/a · PEG n/a · 0% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 25.8 + 4.8 + 12.5 = 43.1 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 6. [Primo Chemicals Ltd](https://www.sectoralpha.in/stocks/primo-chemicals-ltd) PRIMO · quiet · Evidence leans down · 71% evidence 41.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.0/35 · Revenue -2.7% · Profit -15.5% · Operating margin change 0.5 points · 88% evidence Capital efficiency 10.3/25 · ROCE 6.4% · Operating margin 14.8% · 100% evidence Valuation 8.3/20 · P/E 35.1× · PEG n/a · 50% evidence Relative strength 11.6/20 · Lead over its industry n/a · Lead over NIFTY 500 3.7% · 1 year n/a · 25% evidence · 5 of 12 weeks ahead Exact sum: 11 + 10.3 + 8.3 + 11.6 = 41.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Tata Chemicals Ltd](https://www.sectoralpha.in/stocks/tata-chemicals-ltd) TATACHEM · basing · Most evidence points down · 76% evidence 28.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 5.9/35 · Revenue 2% · Profit -80% · Operating margin change -4 points · 88% evidence Capital efficiency 6.1/25 · ROCE 3.4% · Operating margin 13% · 100% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 6.7/20 · Lead over its industry -3.8% · Lead over NIFTY 500 -11.5% · 1 year -33.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 5.9 + 6.1 + 10 + 6.7 = 28.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Inorganic - Caustic Soda/Soda Ash](https://www.sectoralpha.in/sectors/chemicals-inorganic-caustic-soda-soda-ash), all 7 compared on one page. ## Which companies are close to Chemfab Alkalis in size? Chemfab Alkalis is the 7th largest of 7 Chemicals - Inorganic - Caustic Soda/Soda Ash companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Tata Chemicals, Gujarat Alkalies & Chemicals, GHCL, TGV Sraac, Tuticorin Alkali Chemicals & Fertilizers and Primo Chemicals. It is the smallest. ### Chemicals - Inorganic - Caustic Soda/Soda Ash companies close in size

1. [Tata Chemicals Ltd](https://www.sectoralpha.in/stocks/tata-chemicals-ltd) ₹15,174 crore
2. [Gujarat Alkalies & Chemicals Ltd](https://www.sectoralpha.in/stocks/gujarat-alkalies-chemicals-ltd) ₹3,975 crore
3. [GHCL Ltd](https://www.sectoralpha.in/stocks/ghcl-ltd) ₹3,475 crore
4. [TGV Sraac Ltd](https://www.sectoralpha.in/stocks/tgv-sraac-ltd) ₹1,171 crore
5. [Tuticorin Alkali Chemicals & Fertilizers Ltd](https://www.sectoralpha.in/stocks/tuticorin-alkali-chemicals-fertilizers-ltd) ₹579 crore
6. [Primo Chemicals Ltd](https://www.sectoralpha.in/stocks/primo-chemicals-ltd) ₹548 crore
7. Chemfab Alkalis Ltd ₹472 crore

[All 7 Chemicals - Inorganic - Caustic Soda/Soda Ash companies, largest first](https://www.sectoralpha.in/sectors/chemicals-inorganic-caustic-soda-soda-ash#all-companies)

### Companies close in size in other industries

1. [W S Industries (India) Ltd](https://www.sectoralpha.in/stocks/w-s-industries-indialtd) ₹474 crore · General - Electric Equipement
2. [HLV Ltd](https://www.sectoralpha.in/stocks/hlv-ltd) ₹473 crore · Hotels
3. Chemfab Alkalis Ltd ₹472 crore
4. [Credo Brands Marketing Ltd](https://www.sectoralpha.in/stocks/credo-brands-marketing-ltd) ₹472 crore · Textiles - Readymade Apparel
5. [Dhabriya Polywood Ltd](https://www.sectoralpha.in/stocks/dhabriya-polywood-ltd) ₹472 crore · Plastics - Others

## What else do people ask about Chemfab Alkalis? ### What is Chemfab Alkalis's share price today? Chemfab Alkalis Ltd's share price is ₹302.05, −50.4% over the past year. The whole company is worth ₹435 Cr on the market. In the last 52 weeks it traded between ₹291 to ₹556; today it is 4% of the way up from the low, 27.9% below its 200-day average (as of 3 November 2026). ### What were Chemfab Alkalis's latest quarterly results? Chemfab Alkalis Ltd reported revenue of ₹73.2 Cr and net profit of ₹5.7 Cr for the Jun 2026 quarter. Revenue fell 20.1% and profit rose 124.7% compared with a year earlier. Earnings per share were ₹3.99. The operating margin was 13.8%, 1.5 percentage points higher than a year earlier (as of 3 November 2026). ### What is Chemfab Alkalis's market cap? Chemfab Alkalis Ltd's market capitalisation is ₹435 Cr at a share price of ₹302.05. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Chemfab Alkalis performing? Chemfab Alkalis Ltd's share price has been falling for 80 weeks. In its latest quarter, revenue fell 20.1% and profit rose 124.7% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 7 weeks running (as of 3 November 2026). ### Will Chemfab Alkalis's share price go up? This page does not forecast Chemfab Alkalis Ltd's share price. What it shows instead: the share price is ₹302.05, and it has been falling for 80 weeks. Its P/E of 435.0× is higher than 96% of its own last 6 years (as of 3 November 2026). ### Who owns Chemfab Alkalis? Promoters own 72.1% of Chemfab Alkalis Ltd, foreign institutions 0.0%, domestic institutions 0.1% and the public 27.7% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Is Chemfab Alkalis's profit real cash? Yes, over the last 3 years, 149% of Chemfab Alkalis Ltd's reported profit came in as cash from operations. The latest year was lower at -1267%, so the trend is worth watching. In FY26, operating cash was ₹38.0 Cr against reported profit of −₹3.0 Cr. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Chemfab Alkalis in its business cycle? Chemfab Alkalis Ltd's FY26 operating margin was 9.0%, against a 7-year range of 9.0% to 33.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 13.8%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Chemfab Alkalis story? The main question: results are strong, and the P/E is higher than 96% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Chemfab Alkalis a stock worth studying right now? What the numbers show: Chemfab Alkalis Ltd's results are improving, and its P/E is near the top of its own history, higher than 96% of past readings. The main open question: whether earnings grow enough to match the multiple. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.